Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Brigette Ma Kun-Huei Yeh T Yau Ann-Lii Cheng |
| Publication date | September 7, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |